| Document Date: 2014-06-24 19:14:13
Open Document File Size: 183,58 KBShare Result on Facebook
City Malmo / Nuzzo / Melbourne / Comer / Vosburg / Sullivan / / Company Furst RT. / / Continent Europe / / Country United States / Australia / Sweden / Finland / New Zealand / / Event Product Issues / Product Recall / / IndustryTerm treatment of addictive disorders / combination product / combination products / / MedicalCondition generalized anxiety disorder / / MedicalTreatment directly observed therapy / counseling / / Organization Center for Substance Abuse Treatment / / Person Draft / Judith Martin / / Position Governor / drug dealer / pharmacist / nurse / Physician / Sublingual Buprenorphine Original Author / / Product naloxone / relief / Suboxone / opioid / route Buprenorphine-induced / relief Primary buprenorphine effect / Oxycontin / Buprenorphine / / ProvinceOrState South Dakota / Saskatchewan / Pennsylvania / Massachusetts / / PublishedMedium British Medical Journal / / URL http /
SocialTag |
PCSS Guidance Topic: Adherence, Diversion and Misuse of Sublingual Buprenorphine Original Author: Judith Martin, MD Last Updated: [removed]Maria A, Sullivan, M.D., Ph.D.) Guidelines Coverage: